myocardial infarction - Nursing Case Study

Pathophysiology

• Primary mechanism: Atherosclerosis leads to the buildup of plaques in coronary arteries, causing them to narrow and restrict blood flow. When a plaque ruptures, it triggers the formation of a blood clot, completely blocking the artery and depriving the heart muscle of oxygen and nutrients.

• Secondary mechanism: The lack of oxygen (ischemia) quickly leads to the death of myocardial cells (necrosis) within minutes to hours, resulting in the loss of functional heart tissue and impaired contractility.

• Key complication: The necrosis of heart muscle can lead to heart failure, arrhythmias, or even sudden cardiac death due to the heart's inability to effectively pump blood or maintain a normal rhythm.

Patient Profile

Demographics:

55-year-old male, factory worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, diaphoresis, nausea

• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 37.8°C, oxygen saturation 90% on room air

Section 1

As the patient is admitted to the emergency department, an initial assessment is conducted. The patient's electrocardiogram (ECG) shows ST-segment elevation in the anterior leads, confirming a diagnosis of ST-Elevation Myocardial Infarction (STEMI). Blood tests reveal elevated cardiac biomarkers, including troponin I, which supports the diagnosis of acute myocardial infarction. The patient's vital signs continue to be concerning, with persistently elevated blood pressure at 152/98 mmHg and a heart rate that has risen to 115 bpm. Oxygen saturation remains low at 90% despite supplemental oxygen via a nasal cannula. The patient's respiratory rate is 26 breaths per minute, indicating increasing respiratory distress.

Despite initial interventions, including the administration of nitroglycerin and morphine for pain relief, the patient begins to exhibit signs of acute heart failure. Auscultation reveals crackles at the lung bases, suggesting pulmonary congestion. The patient’s jugular venous pressure is elevated, and peripheral edema is developing. These findings indicate that the myocardial infarction has impaired the heart's ability to pump effectively, leading to fluid backup in the lungs and systemic circulation. These symptoms necessitate the initiation of diuretics to reduce fluid overload and further oxygen therapy to improve oxygenation.

Given the patient’s rapid progression to heart failure, the healthcare team decides to prepare for urgent coronary angiography and possible percutaneous coronary intervention (PCI) to restore blood flow to the affected coronary artery. This decision is crucial to limit the extent of myocardial damage and prevent further deterioration. The risk of arrhythmias or cardiogenic shock remains a concern, requiring continuous cardiac monitoring and readiness to escalate care if the patient's condition worsens. The unfolding situation emphasizes the importance of timely intervention and vigilant monitoring to manage complications associated with myocardial infarction effectively.

Section 2

As the healthcare team continues to monitor the patient, a sudden change in the patient's status is observed. The patient's heart rate has now increased to 125 bpm, and there is a noticeable drop in blood pressure to 88/56 mmHg, indicating potential progression towards cardiogenic shock. The patient appears increasingly diaphoretic and anxious, and auscultation reveals more pronounced crackles in the lungs, extending to the mid-lung fields. The oxygen saturation has further decreased to 85% despite the use of a non-rebreather mask with 100% oxygen. Given these alarming developments, the medical team urgently reassesses the patient's treatment plan.

In response to these changes, intravenous inotropic support is initiated to improve cardiac contractility and support blood pressure. Dobutamine is selected as the inotrope of choice due to its ability to enhance myocardial contractility while reducing systemic vascular resistance. The patient's fluid status is reassessed, and diuretic therapy is adjusted accordingly to manage the pulmonary congestion. Additionally, a repeat ECG is performed, revealing worsening ST-segment elevations and the emergence of new Q waves, suggesting ongoing myocardial ischemia or infarction.

The healthcare team acknowledges the heightened risk of arrhythmias and potential for further hemodynamic instability, necessitating the initiation of continuous cardiac monitoring and preparation for advanced cardiac life support if needed. The decision to proceed with the urgent coronary angiography and possible PCI is reaffirmed, emphasizing the critical need to revascularize the compromised coronary artery. This scenario underscores the dynamic nature of myocardial infarction management, requiring timely interventions and adaptive clinical reasoning to address evolving complications and optimize patient outcomes.

Section 3

As the medical team continues to manage the patient, attention shifts to the response to the initiated interventions. The administration of dobutamine appears to stabilize the patient's hemodynamics initially, with a modest improvement in blood pressure to 100/60 mmHg and a slight reduction in heart rate to 115 bpm. However, the patient remains tachycardic and hypotensive, indicating partial efficacy of the inotropic support. The diuretic adjustment begins to alleviate the pulmonary congestion, with auscultation revealing a slight reduction in crackles, now restricted to the lower lung fields, and the patient's respiratory effort appears less labored. Despite these improvements, oxygen saturation remains concerningly low at 88%, even with high-flow oxygen, suggesting ongoing challenges with oxygenation, possibly due to persistent pulmonary edema or evolving cardiac complications.

Simultaneously, the repeat ECG results prompt immediate attention from the cardiology team. The newly emerged Q waves and worsening ST-segment elevations reinforce the urgency of revascularization, as these changes suggest extensive myocardial damage. Serum biomarkers also reveal elevated troponin levels, further confirming the extent of myocardial injury. The patient's chest pain persists, albeit diminished, pointing towards partial ischemia relief but insufficient myocardial perfusion.

Recognizing the potential for arrhythmic complications, particularly ventricular tachycardia or fibrillation, continuous cardiac monitoring is intensified. The team remains vigilant for any signs of electrical instability. The decision to proceed with urgent coronary angiography is expedited, as it becomes increasingly clear that timely intervention is crucial to prevent further myocardial necrosis and limit long-term cardiac dysfunction. The patient's journey underscores the necessity of swift clinical reasoning and targeted interventions to mitigate the progression of myocardial infarction and enhance recovery prospects.

Section 4

As the medical team prepares for the urgent coronary angiography, new diagnostic results reveal further complications in the patient's condition. The latest arterial blood gas analysis shows a persistent metabolic acidosis with a pH of 7.30, bicarbonate level at 18 mmol/L, and a base deficit of -8 mmol/L, indicating inadequate tissue perfusion and ongoing cellular hypoxia despite the inotropic support. Lactate levels have also risen to 4.5 mmol/L, corroborating the presence of tissue hypoperfusion and suggesting that systemic circulation remains compromised.

Additionally, the renal panel shows a concerning increase in serum creatinine to 2.1 mg/dL from a baseline of 1.0 mg/dL, alongside oliguria of less than 30 mL/hour. These findings suggest the onset of acute kidney injury, likely secondary to both reduced cardiac output and potential nephrotoxic effects of contrast agents used in earlier imaging procedures. The patient's electrolyte panel reveals potassium levels have elevated to 5.8 mmol/L, raising the risk of cardiac arrhythmias and complicating the hemodynamic management.

In light of these developments, the clinical focus intensifies on optimizing renal perfusion while balancing the risks of fluid overload and electrolyte imbalances. The interdisciplinary team discusses the potential need for renal replacement therapy if renal function continues to deteriorate. Continuous cardiac monitoring remains critical as the team anticipates the coronary angiography, with plans to address the identified multiorgan impacts promptly. This scenario highlights the intricate balance required in managing myocardial infarction complications and the importance of timely intervention to improve patient outcomes.

Section 5

As the medical team prepares the patient for coronary angiography, a sudden change in the patient's status necessitates immediate attention. The patient's heart rate, previously stable on inotropic support, has now escalated to 110 beats per minute with irregular rhythm while the blood pressure has dropped to 85/50 mmHg, indicating worsening hemodynamic instability. The continuous cardiac monitoring reveals frequent premature ventricular contractions (PVCs), likely exacerbated by the elevated potassium levels. These arrhythmias pose a significant risk, prompting the team to administer intravenous calcium gluconate to stabilize the cardiac membrane and initiate insulin with glucose to shift potassium intracellularly.

In parallel, the patient's respiratory status becomes increasingly compromised, with oxygen saturation dropping to 88% on high-flow nasal cannula. Auscultation reveals diffuse crackles, suggesting developing pulmonary edema as a consequence of both fluid resuscitation and heart failure. The team promptly administers diuretics to manage fluid overload while assessing the need for non-invasive ventilation support to improve oxygenation and alleviate respiratory distress.

These developments underscore the precarious balance in managing the patient’s multiple organ system challenges. The intensified focus on stabilizing cardiac rhythm, managing fluid status, and optimizing oxygen delivery is critical to preventing further deterioration. As preparations continue for the angiography, the team remains vigilant, recognizing that timely intervention could significantly alter the trajectory of the patient’s recovery and mitigate the risks of further complications.